In May 2025, Illumina, Inc., and Ovation.io, Inc., announced the development of the largest commercially available clinical multiomic dataset from 25,000 patients treated with glucagon-like peptide-1 (GLP-1) receptor agonist therapies
HardanAYFungLKLiboveRAObukhanychTVNairSHerzenbergLAet al
The goal is to minimize inappropriate mediator release and reduce baseline reactivity
DOI: 10.1016/j.ejmech.2015.04.040 2
A total of 1097 compounds from the ICR biophysical fragment library 39 were screened in pools of four structurally dissimilar molecules with non-overlapping resonances in the aromatic region of the 1 H spectrum (5.59.5 ppm)
Naming matters because BPC-157 appears in literature as BPC 157, pentadecapeptide BPC 157, gastric pentadecapeptide, and stable gastric pentadecapeptide BPC 157